MIG-ES-NP-00141 (Marzo 2024) 

Dr. José Miguel Láinez, Dr. Mariano Huerta, Dra. Carmen González Oria, Dr. Pablo Irimia Sieira. Clínica, Dra. Isabel Beltrán Blasco, Dr. Juan Carlos García-Moncó y Dr. David García Azorín

Sesiones relacionadas en este debate:

• ​What's next after CGRP?​
• CGRP antagonists 5 years in - what have we learned?​
• Additional options when classic or new drugs are not effective or not available​
• New treatments in childhood headache​
• The non-responders: It is not all about CGRP​
• Biological sex in clinical trial outcomes
  

MIG-ES-NP-00142 (Marzo 2024) 

Dr. José Miguel Láinez, Dr. Rogelio Leira Muiño, Dr. Samuel Díaz Insa, Dra. Noemí Morollón Sánchez, Dra. Sonia Santos Lasaosa, Dra. Marta Torres Ferrús y Dr. David Ezpeleta

Sesiones relacionadas en este debate:​

MIG-ES-NP-00143 (Marzo 2024) 

Dr. José Miguel Láinez, Dra. Patricia Pozo-Rosich, Dr. Jesús Porta-Etessam, Dr. Julio Pascual, Dr. Javier Viguera, Dr. Ángel Luis Guerrero, Dr. Francisco José Molina Martínez y Dra. Candela Nieves Castellanos

Sesiones relacionadas en este debate:

• Chronic cluster headache management
• The science behind migraine and neuropsychiatric comorbidity
• New developments in acute and preventive medications
• Burden of headaches
• Cognitive dysfunction in migraine: Myth or reality?
• Dizziness in migraine and pathophysiology of vestibular migraine

MIG-ES-NP-00144 (Marzo 2024) 

Dr. José Miguel Láinez, Dra. Patricia Pozo-Rosich, Dr. Roberto Belvís Nieto, Dr. Javier Díaz de Terán, Dr. Jaime Rodríguez Vico, Dra. Mª Luz Cuadrado Pérez y Dra. Ana Gago Veiga

Sesiones relacionadas en este debate:

• Does real-world evidence have a role in headache medicine?
• Complementary medicine for headaches: The colours of mind
• Headaches associated with vascular events
• Medication overuse: A new story?
• How to assess quality of life in clinical practice